Clinical trial
Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes
NCT00004404 · Boston Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00004404 |
|---|---|
| Title | Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes |
| Lead sponsor | Boston Children's Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Sickle Cell Anemia |
| Intervention type | Drug |
| Interventions | clotrimazole, hydroxyurea |
| Enrollment | 20 |
| Start date | Apr 1, 1997 |
| Completion | Sep 1, 2002 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: